Latest current assets for RGC: $14M.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
Regencell Bioscience Holdings (RGC) currently reports a current assets of $14M as of June 2026. That compares with $4.9M in the prior-year period — up 190.1% year over year. Use the charts on this page to explore Regencell Bioscience Holdings's current assets history and peer comparisons.
Regencell Bioscience Holdings's current assets increased from $4.9M to $14M — a 190.1% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Regencell Bioscience Holdings reported $14M in current assets as of June 2026. That compares with $4.9M in the prior-year period — up 190.1% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current current assets of $14M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Regencell Bioscience Holdings, and consider following RGC for alerts when major investors trade the stock.
Regencell Bioscience Holdings is classified in the Healthcare sector. On current assets, it currently shows $14M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing RGC with unrelated industries.